Growth Metrics

Integra Lifesciences Holdings (IART) Total Debt Growth (3y) (2012 - 2026)

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt Growth (3y) (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 26.30%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 4.07%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn -0.07%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 6.99%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 0.11%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 1.72%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn -
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn -0.34%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn -14.39%
10 Integra Lifesciences Holdings 1.20 Bn 939.16 Mn 216.98 Mn 32.50%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 32.50%
Dec 31, 2025 31.86%
Sep 30, 2025 25.20%
Jun 30, 2025 9.95%
Mar 31, 2025 10.30%
Dec 31, 2024 24.09%
Sep 30, 2024 10.16%
Jun 30, 2024 10.64%
Mar 31, 2024 7.15%
Dec 31, 2023 -5.14%
Sep 30, 2023 -3.83%
Jun 30, 2023 -8.93%
Mar 31, 2023 -8.92%
Dec 31, 2022 -14.72%
Sep 30, 2022 -12.93%
Jun 30, 2022 -11.36%
Mar 31, 2022 -11.12%
Dec 31, 2021 -11.00%
Sep 30, 2021 -15.23%
Jun 30, 2021 -16.31%
Mar 31, 2021 -19.17%
Dec 31, 2020 -18.76%
Sep 30, 2020 -6.20%
Jun 30, 2020 5.00%
Mar 31, 2020 4.75%
Dec 31, 2019 23.20%
Sep 30, 2019 41.81%
Jun 30, 2019 37.33%
Mar 31, 2019 34.48%
Dec 31, 2018 35.44%
Sep 30, 2018 40.59%
Jun 30, 2018 50.23%
Mar 31, 2018 65.81%
Dec 31, 2017 62.96%
Sep 30, 2017 41.68%
Jun 30, 2017 27.77%
Mar 31, 2017 28.05%
Dec 31, 2016 52.67%
Sep 30, 2016 10.60%
Jun 30, 2016 12.17%
Mar 31, 2016 16.53%
Dec 31, 2015 15.52%
Sep 30, 2015 16.82%
Jun 30, 2015 10.72%
Mar 31, 2015 34.04%
Dec 31, 2014 32.38%
Sep 30, 2014 28.86%
Jun 30, 2014 42.97%
Mar 31, 2014 26.94%
Dec 31, 2013 -9.02%
Sep 30, 2013 17.18%
Jun 30, 2013 15.83%
Dec 31, 2012 10.78%